Showing 2301-2310 of 3871 results for "".
- BeautyHealth Launches New Hydrafacial School Partner Program for Student Estheticianshttps://modernaesthetics.com/news/beautyhealth-launches-new-hydrafacial-school-partner-program-for-student-estheticians/2473505/The Beauty Health Company is introducing the Hydrafacial School Partner Program to accredited esthetic schools across the U.S. Piloted first with select Paul Mitchell Schools and Aveda Institute locations, the Hydrafacial School Partner Program offers participating schools and the
- Galderma Gives Back: New “Facing Breast Cancer Together" Campaign Supports the National Breast Cancer Foundationhttps://modernaesthetics.com/news/galderma-gives-back-new-facing-breast-cancer-together-campaign-supports-the-national-breast-cancer-foundation/2473503/Galderma is launching a new campaign to provide education and support for breast cancer awareness as part of its nine-year partnership with National Breast Cancer Foundation (NBCF), Inc. The survival rate of breast cancer patients has significantly increased due to early diagnosis
- New In My Practice: The Viality Fat Transfer System by Sientra with Dr. David Shaferhttps://modernaesthetics.com/news/new-in-my-practice-the-viality-fat-transfer-system-by-sientra-with-david-shafer-md/2473501/AestheticsWire recently sat down with New York City plastic surgeon David Shafer, MD to discuss how the use of the Viality Fat Transfer System by Sientra has improved his fat transfer procedures. AestheticsWire: What is the Viality Fat Transfer System by Sientra?<
- ISAPS 2022 Data: Liposuction Remains the Most Popular Plastic Surgery Procedure in the Worldhttps://modernaesthetics.com/news/isaps-2022-data-liposuction-remains-the-most-popular-plastic-surgery-procedure-in-the-world/2473494/Liposuction is continuing its reign as the most popular surgical procedure across the globe, according to the newest statistics from the International Society of Aesthetic Plastic Surgery (ISAPS). The US also retained
- Cutera Introduces Secret DUOhttps://modernaesthetics.com/news/cutera-introduces-secret-duo/2473490/Cutera, Inc. is launching Secret DUO, a skin resurfacing and revitalization platform that utilizes dual non-ablative fractional technologies. Each modality can be used individually or in combination to target a wide range of aesthetic indications. Secret DUO is equipped
- SkinCeuticals Launches National Treatment Tourhttps://modernaesthetics.com/news/skinceuticals-launches-national-treatment-tour/2473489/SkinCeuticals is kicking off its national treatment tour. The SkinCeuticals Treatment Tour aims to spread awareness on the importance of pairing treatments and skincare for optimal results and offers an op
- BBL Safety Update: AACS Supports New Florida Bill Mandating Ultrasound-guided BBL Surgeryhttps://modernaesthetics.com/news/bbl-safety-update-aacs-supports-new-florida-bill-mandating-ultrasound-guided-bbl-surgery/2473483/The American Academy of Cosmetic Surgery (AACS) strongly commends the Florida legislature for its ongoing commitment to promoting patient safety in Brazilian Butt Lift (BBL) surgery and applauds the recent legislative decision that mand
- New Approach Quantifies the Hydraulic Permeability of Skin, Revealing the Spongelike Properties of the Dermishttps://modernaesthetics.com/news/new-approach-quantifies-the-hydraulic-permeability-of-skin-revealing-the-spongelike-properties-of-the-dermis/2473480/A new approach to quantify the hydraulic permeability of skin reveals the spongelike properties of the dermis layer, according to a study in PNAS Nexus. For the study, Alan J. Grodz
- FDA Green Lights Sentient's Tixel for Periorbital Wrinkleshttps://modernaesthetics.com/news/fda-green-lights-sentients-tixel-for-periorbital-wrinkles/2473479/The U.S. Food and Drug Administration has approved Tixel by Sentient for the treatment of peri
- 10xBio Completes Enrollment of Phase 2b Trial of Novel Drug for Submental Body Contouringhttps://modernaesthetics.com/news/10xbio-completes-enrollment-of-phase-2b-trial-of-novel-drug-for-submental-body-contouring/2473477/10xBio completed enrollment in a repeat treatment study of its novel injectable drug for submental body contouring. The drug, 10